Article info

Download PDFPDF
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study

Authors

  • Fang-Xiao Zhu Department of Rheumatology and Immunology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China PubMed articlesGoogle scholar articles
  • Jing-Yang Huang Department of Medical Research, Chung Shan Medical University Hospital, Taichung City, Taiwan, Taiwan Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Zhizhong Ye Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Shenzhen, Guangdong, China PubMed articlesGoogle scholar articles
  • Qing-Qing Wen Department of Rheumatology and Immunology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China PubMed articlesGoogle scholar articles
  • James Cheng-Chung Wei Department of Rheumatology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung, Taiwan Chung Shan Medical University Hospital, Taichung, Taiwan Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr James Cheng-Chung Wei, Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; jccwei{at}gmail.com
View Full Text

Citation

Zhu F, Huang J, Ye Z, et al
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study

Publication history

  • Received January 22, 2020
  • Revised March 13, 2020
  • Accepted March 17, 2020
  • First published April 2, 2020.
Online issue publication 
May 20, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.